19It should furthermore be noted that:— pursuant to Article 1(b) of the regulation, the term product as used in the regulation is defined as an active ingredient or combination of active ingredients of a medicinal product;— pursuant to Article 3 of the regulation, the certificate is to be granted, inter alia, provided that the product has been granted a marketing authorisation as a medicinal product in accordance with Directive 65/65 or Directive 81/851; and— pursuant to Article 4 of the regulation, the protection conferred by a certificate is to extend only to the product covered by the marketing authorisation for the corresponding medicinal product for any use of the product as a medicinal product that has been authorised before the expiry of the certificate.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.